Curadex is a 2nd generation synthetic, broad spectrum quinolone.
Curadex has in-vitro activity against a broad spectrum of gram +ve and gram –ve aerobic and anaerobic bacteria.

- Gastro intestinal infection
- Typhoid
- Pancreatitis
- Multi drug resistant TB
- Sexually transmitted diseases
- Pelvic inflammatory disease
- Acute uncomplicated urethral and cervical gonorrhoea
- Nongonococcal urethritis and cervicitis
- Uncomplicated cystitis
- Mixed infections of the urethra and cervix
- Urinary tract infections

Product Variants & Features

Product Strength Presentation Features
Curadex / Zofex Each 100 ml contains:
Ofloxacin-200 mg
water for injection-q.s.
100 ml in PE bottle

- Extended antibacterial coverage against both-aerobes and anaerobes
- Excellent penetration into pleural fluid, macrophages
- Recommended by CDC and WHO for MDR-TB
- Only quinolone recommended by USFDA for pelvic inflammatory disease